Business Parks & Science Centres

 
 
 

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
Organisation › Details

Gotham Therapeutics Corporation

Gotham Therapeutics has assembled an exceptional team and network to establish a novel drug class targeting RNA-modifying proteins. By changing the activity of proteins that modify messenger RNA, we aim to develop new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. We are applying a 360-degree approach to small molecule drug design to build a pipeline based on the promise of this rapidly emerging biopharmaceutical field. *

 

Period Start 2018-10-10 existent
  Group Gotham Therapeutics (Group)
Product Industry  drug discovery
Persons Person Babiss, Lee E. (Gotham Therapeutics 201810 CEO before Roche+ PPD + Glaxo Wellcome)
  Person 2 Zech, Birgit (Gotham Therapeutics 201708– COO before X-Rx + MAB Discovery + Pieris + Axxima)
     
  Street 430 East 29th Street
  City 10016 New York, NY
    Address record changed: 2018-12-15
     
Basic data Employees n. a.
     
    * Document for �About Section�: Gotham Therapeutics Corporation. (10/10/18). "Press Release: Gotham Therapeutics Launches with $54 Million Series A". New York, NY.
     
   
Record changed: 2018-10-31

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Gotham Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px




» top